Strong Q3 Growth for SS Innovations Sets Future Path

SS Innovations International, Inc. Third Quarter 2025 Financial Results

SS Innovations International, Inc. (NASDAQ: SSII), a pioneering company in developing surgical robotic technologies, recently announced its financial results for the third quarter ending September 30, 2025. The unaudited results reflect substantial growth and strategic advancements in the company's operations.

Third Quarter Highlights

The third quarter of 2025 demonstrated remarkable performance for SS Innovations, continuing the momentum built in previous quarters:

• Revenue surged by 192.5%, reaching $12.8 million compared to $4.4 million in the same period last year.
• Gross profit saw a significant increase of 166.0%, amounting to $6.2 million against $2.3 million from Q3 2024.
• Despite the revenue growth, the net loss was recorded at $3.7 million, consistent with the previous year's loss.
• Installation of the SSi Mantra surgical robotic system increased dramatically, with a total of 27 installations, a 350.0% rise from last year's six installations.

Key Performance Metrics

In addition to the remarkable revenue increases, the company's gross margin was slightly lower at 48.1% compared to 52.8% in Q3 2024. However, the overall financial health remains strong, with no long-term debt reported and cash and cash equivalents reported at $5.7 million, excluding restricted cash.

Performance Over the First Nine Months

When looking at the first nine months of 2025, the company reported:

• A revenue increase of 123.0%, totaling $28.0 million as opposed to $12.5 million during the same period in 2024.
• The gross profit climbed to $13.2 million, up 193.7% from last year's $4.5 million.
• The net loss reduced significantly to $9.7 million, compared to a loss of $17.2 million from the first nine months of 2024.
• SS Innovations installed 63 SSi Mantra systems during the year, highlighting its growing footprint in the medical robotic landscape.

Regulatory Approvals and Market Entry

Dr. Sudhir Srivastava, Chairman and CEO, noted the company's commitment to delivering affordable robotic surgical solutions globally. With regulatory approvals in seven countries, the company is poised for future growth, planning to enter both the U.S. and European markets. A successful human factors validation study was recently completed, paving the way for a 510(k) submission to the FDA.

Highlights from the CEO

Dr. Srivastava remarked on the positive trajectory of the company, emphasizing their leadership in the Indian market and their goal of democratizing access to advanced surgical care. He stated, "The increasing utilization of our SSi Mantra system reflects our dedication to delivering high-quality, cost-effective medical solutions that improve surgical outcomes across diverse patient populations. We are excited about the future as we aim to expand our market presence further and enhance our product offerings."

Recent Innovations and Achievements

This quarter was also marked by several notable achievements, including:

• The successful execution of the world's first pediatric pyeloplasty telesurgery, demonstrating the SSi Mantra's capabilities.
• The appointment of Naveen Kumar Amar as Chief Financial Officer, aimed at strengthening the company's financial strategy.
• Completion of a human factors validation study, deemed essential for the upcoming FDA submission.

Conclusion and Future Outlook

SS Innovations International, Inc. is on a strong growth trajectory, revolutionizing surgical robotics in both established and emerging markets. The financial results from the third quarter and first nine months of 2025 indicate a robust demand for their innovations. As the company navigates toward regulatory approval in key markets, it remains dedicated to expanding its product lines and enhancing access to robotic surgical solutions globally.

Frequently Asked Questions

1. What were SS Innovations' revenue figures for Q3 2025?

In Q3 2025, SS Innovations reported a revenue of $12.8 million, which is a 192.5% increase from the previous year's $4.4 million.

2. How many SSi Mantra systems were installed in the latest quarter?

The company installed 27 SSi Mantra surgical robotic systems in Q3 2025, representing a 350.0% increase from the prior year.

3. What was the net loss reported for the first nine months of 2025?

SS Innovations experienced a net loss of $9.7 million for the first nine months of 2025, which is an improvement over the $17.2 million loss in the same period in 2024.

4. What future plans does SS Innovations have for market expansion?

SS Innovations plans to enter the U.S. and European markets following the completion of regulatory approvals in seven countries.

5. Who is the current CEO of SS Innovations?

Dr. Sudhir Srivastava serves as the Chairman and CEO of SS Innovations, steering the company towards its goals of global expansion and access to advanced surgical technology.

About The Author

Hey there I'm Caleb Price, a writer and financial specialist who loves to assist others in understanding the financial world. Having years of practical experience and a solid background in finance, my area of expertise is converting difficult financial ideas into useful, doable insights for my blog and publications. My goal with my writing is to give readers the information and assurance they need to successfully negotiate their financial journeys.

My ability to interact with a wide range of people—from novices starting their investing journey to seasoned investors looking for new approaches—has come from contributing to several financial blogs. Making money approachable and understandable is my goal; this will enable you to make wise choices and realize your financial objectives. We appreciate you coming along on this path to success and financial empowerment on Investors Hangout.

Contact Caleb Price privately here. Or send an email with ATTN: Caleb Price as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.